Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor in Synucleinopathy-Related Constipation
NCT06460038Phase 2Recruiting
- Sponsor
- Cedar Valley Digestive Health Center
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenapanor in constipation, sponsored by Cedar Valley Digestive Health Center. Started Jan 2025; status: recruiting.
02
Drugs
tenapanor
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06460038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06460038.